Table of Content

"1    INTRODUCTION    32
1.1    OBJECTIVES OF THE STUDY    32
1.2    MARKET DEFINITION    33
1.2.1    INCLUSIONS & EXCLUSIONS    33
1.3    MARKET SCOPE    34
1.3.1    MARKETS COVERED    34
1.3.2    YEARS CONSIDERED FOR THE STUDY    35
1.4    CURRENCY USED FOR THE STUDY    35
1.5    MARKET STAKEHOLDERS    35
1.6    LIMITATIONS    36
1.7    SUMMARY OF CHANGES    36
2    RESEARCH METHODOLOGY    37
2.1    RESEARCH DATA    37
FIGURE 1    RESEARCH DESIGN    37
2.1.1    SECONDARY DATA    38
2.1.1.1    Secondary sources    39
2.1.2    PRIMARY DATA    39
FIGURE 2    BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION    40
2.2    MARKET ESTIMATION METHODOLOGY    40
FIGURE 3    RESEARCH METHODOLOGY: HYPOTHESIS BUILDING    41
2.2.1    VENDOR REVENUE-BASED MARKET SIZE ESTIMATION    41
FIGURE 4    MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH    42
2.2.2    END USER-BASED MARKET SIZE ESTIMATION    42
FIGURE 5    ULTRASOUND MARKET: END USER-BASED ESTIMATION    43
2.2.3    PRIMARY RESEARCH VALIDATION    43
2.3    COVID-19 HEALTH ASSESSMENT    43
2.4    COVID-19 ECONOMIC ASSESSMENT    44
2.5    ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO    44
FIGURE 6    CRITERIA IMPACTING THE GLOBAL ECONOMY    44
FIGURE 7    RECOVERY SCENARIO OF THE GLOBAL ECONOMY    45
2.6    DATA TRIANGULATION    46
FIGURE 8    DATA TRIANGULATION METHODOLOGY    46
2.7    RESEARCH ASSUMPTIONS    47
2.8    RESEARCH LIMITATIONS    47

3    EXECUTIVE SUMMARY    48
FIGURE 9    ULTRASOUND MARKET, BY TECHNOLOGY, 2021 VS. 2026 (USD MILLION)    48
FIGURE 10    ULTRASOUND MARKET SHARE, BY DISPLAY TYPE, 2021 VS. 2026    49
FIGURE 11    ULTRASOUND MARKET, BY SYSTEM PORTABILITY,
2021 VS. 2026 (USD MILLION)    49
FIGURE 12    ULTRASOUND MARKET, BY APPLICATION, 2021 VS. 2026 (USD MILLION)    50
FIGURE 13    ULTRASOUND MARKET SHARE, BY END USER, 2021 VS. 2026    51
FIGURE 14    GEOGRAPHICAL SNAPSHOT OF THE ULTRASOUND MARKET    52
4    PREMIUM INSIGHTS    53
4.1    ULTRASOUND MARKET OVERVIEW    53
FIGURE 15    TECHNOLOGICAL ADVANCEMENTS AND INCREASING PREVALENCE OF TARGET DISEASES TO DRIVE THE GROWTH OF THE ULTRASOUND MARKET    53
4.2    EUROPE: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE AND COUNTRY    54
FIGURE 16    GERMANY IS THE LARGEST MARKET FOR DIAGNOSTIC ULTRASOUND IN EUROPE    54
4.3    ULTRASOUND MARKET, BY APPLICATION, 2021 VS. 2026 (USD MILLION)    55
FIGURE 17    VASCULAR APPLICATIONS SEGMENT TO REGISTER SUBSTANTIAL GROWTH IN THE GLOBAL ULTRASOUND MARKET    55
4.4    GEOGRAPHIC SNAPSHOT OF THE ULTRASOUND MARKET    55
FIGURE 18    CHINA TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD    55
5    MARKET OVERVIEW    56
5.1    INTRODUCTION    56
5.2    MARKET DYNAMICS    56
FIGURE 19    ULTRASOUND MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES    56
5.2.1    DRIVERS    57
5.2.1.1    Increasing prevalence of target diseases    57
5.2.1.2    Rising patient preference for minimally invasive procedures    57
5.2.1.3    Technological advancements    58
TABLE 1    RECENT PRODUCT LAUNCHES/APPROVALS IN THE ULTRASOUND MARKET    58
5.2.1.4    Growing public and private investments, funding, and grants    59
5.2.1.5    Increasing number of diagnostic centers & hospitals    59
5.2.2    RESTRAINTS    60
5.2.2.1    Unfavorable healthcare reforms in the US    60
5.2.3    OPPORTUNITIES    60
5.2.3.1    Expanding applications of therapeutic ultrasound    60
5.2.3.2    Emerging markets    61
5.2.3.3    Development of POC ultrasound devices    61
5.2.4    CHALLENGES    62
5.2.4.1    Growing end-user preference for refurbished equipment    62
5.2.4.2    Dearth of skilled and well-trained sonographers    62
5.3    INDUSTRY TRENDS    62
5.3.1    DEVELOPMENT OF APPLICATION-SPECIFIC ULTRASOUND DEVICES    62
5.3.2    GROWING USE OF ULTRASOUND IN ELASTOGRAPHY    63
5.3.3    INCREASING USE OF MR-GUIDED ULTRASOUND MODALITIES IN NEUROLOGY APPLICATIONS    63
5.4    PRICING TREND ANALYSIS (2017–2020)    64
5.4.1    NORTH AMERICA    64
5.4.2    EUROPE    64
5.4.3    ASIA PACIFIC    65
5.4.4    REST OF THE WORLD    65
5.5    VALUE CHAIN ANALYSIS    66
FIGURE 20    VALUE CHAIN ANALYSIS: MAXIMUM VALUE IS ADDED DURING THE MANUFACTURING PHASE    66
5.6    REGULATORY ANALYSIS    67
5.6.1    NORTH AMERICA    67
5.6.1.1    US    67
TABLE 2    US FDA: MEDICAL DEVICE CLASSIFICATION    67
TABLE 3    US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS    68
5.6.1.2    Canada    68
TABLE 4    CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS    68
FIGURE 21    CANADA: REGULATORY APPROVAL PROCESS FOR MEDICAL DEVICES    69
5.6.2    EUROPE    70
FIGURE 22    EUROPE: REGULATORY APPROVAL PROCESS FOR MEDICAL DEVICES (MDR)    71
5.6.3    ASIA PACIFIC    72
5.6.3.1    Japan    72
TABLE 5    JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA    72
5.6.3.2    China    73
TABLE 6    CHINA: CLASSIFICATION OF MEDICAL DEVICES    73
5.6.3.3    India    74
5.7    PORTER’S FIVE FORCES ANALYSIS    75
TABLE 7    ULTRASOUND MARKET: PORTER’S FIVE FORCES ANALYSIS    75
5.7.1    THREAT OF NEW ENTRANTS    75
5.7.2    THREAT OF SUBSTITUTES    75
5.7.3    BARGAINING POWER OF SUPPLIERS    76
5.7.4    BARGAINING POWER OF BUYERS    76
5.7.5    DEGREE OF COMPETITION    76
5.8    COVID-19 IMPACT ON THE ULTRASOUND MARKET    76
5.9    ECOSYSTEM COVERAGE: ULTRASOUND MARKET    78
5.10    PATENT ANALYSIS    79
FIGURE 23    TOP 10 PATENT APPLICANTS FOR ULTRASOUND (DECEMBER 2021)    79
FIGURE 24    PATENT APPLICATIONS FOR ULTRASOUND
(JANUARY 2011 TO DECEMBER 2021)    79
FIGURE 25    TOP 10 PATENT APPLICANTS FOR THERAPEUTIC ULTRASOUND
(JANUARY 2011 TO AUGUST 2021)    80
FIGURE 26    PATENT APPLICATIONS FOR THERAPEUTIC ULTRASOUND
(JANUARY 2011 TO DECEMBER 2021)    80
FIGURE 27    TOP 10 PATENT APPLICANTS FOR POINT-OF-CARE ULTRASOUND
(JANUARY 2011 TO AUGUST 2021)    81
FIGURE 28    PATENT APPLICATIONS FOR POINT-OF-CARE ULTRASOUND
(JANUARY 2011 TO DECEMBER 2021)    81
5.11    TRADE ANALYSIS FOR ULTRASOUND SYSTEMS    82
TABLE 8    IMPORT DATA FOR ULTRASOUND SYSTEMS, BY COUNTRY,
2016–2020 (USD MILLION)    82
TABLE 9    EXPORT DATA FOR ULTRASOUND SYSTEMS, BY COUNTRY,
2016–2020 (USD MILLION)    82
6    ULTRASOUND MARKET, BY TECHNOLOGY    83
6.1    INTRODUCTION    84
TABLE 10    ULTRASOUND MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)    84
6.2    DIAGNOSTIC ULTRASOUND    84
TABLE 11    DIAGNOSTIC ULTRASOUND MARKET, BY TYPE, 2019–2026 (USD MILLION)    84
TABLE 12    DIAGNOSTIC ULTRASOUND MARKET, BY REGION,
2019–2026 (USD MILLION)    85
6.2.1    DIAGNOSTIC ULTRASOUND MARKET, BY DISPLAY TYPE,
2019–2026 (USD MILLION)    85
TABLE 13    DIAGNOSTIC ULTRASOUND MARKET, BY DISPLAY TYPE,
2019–2026 (USD MILLION)    85
6.2.2    DIAGNOSTIC ULTRASOUND MARKET, BY SYSTEM PORTABILITY,
2019–2026 (USD MILLION)    86
TABLE 14    DIAGNOSTIC ULTRASOUND MARKET, BY SYSTEM PORTABILITY,
2019–2026 (USD MILLION)    86
6.2.3    DIAGNOSTIC ULTRASOUND MARKET, BY APPLICATION,
2019–2026 (USD MILLION)    86
TABLE 15    DIAGNOSTIC ULTRASOUND MARKET, BY APPLICATION,
2019–2026 (USD MILLION)    86
6.2.4    DIAGNOSTIC ULTRASOUND MARKET, BY END USER,
2019–2026 (USD MILLION)    87
TABLE 16    DIAGNOSTIC ULTRASOUND MARKET, BY END USER,
2019–2026 (USD MILLION)    87
6.2.5    2D ULTRASOUND    87
6.2.5.1    Strong market demand from less-developed and emerging countries to sustain the growth of this segment    87
TABLE 17    2D ULTRASOUND MARKET, BY REGION, 2019–2026 (USD MILLION)    88
6.2.6    2D ULTRASOUND MARKET, BY DISPLAY TYPE, 2019–2026 (USD MILLION)    88
TABLE 18    2D ULTRASOUND MARKET, BY DISPLAY TYPE, 2019–2026 (USD MILLION)    88
6.2.7    2D ULTRASOUND MARKET, BY SYSTEM PORTABILITY,
2019–2026 (USD MILLION)    89
TABLE 19    2D ULTRASOUND MARKET, BY SYSTEM PORTABILITY,
2019–2026 (USD MILLION)    89
6.2.8    2D ULTRASOUND MARKET, BY APPLICATION, 2019–2026 (USD MILLION)    89
TABLE 20    2D ULTRASOUND MARKET, BY APPLICATION, 2019–2026 (USD MILLION)    89
6.2.9    2D ULTRASOUND MARKET, BY END USER, 2019–2026 (USD MILLION)    90
TABLE 21    2D ULTRASOUND MARKET, BY END USER, 2019–2026 (USD MILLION)    90
6.2.10    3D AND 4D ULTRASOUND    90
6.2.10.1    Greater diagnostic accuracy and improved imaging capabilities to boost the global market demand for 3D/4D ultrasound    90
TABLE 22    3D AND 4D ULTRASOUND MARKET, BY REGION, 2019–2026 (USD MILLION)    91
6.2.11    3D AND 4D ULTRASOUND MARKET, BY DISPLAY TYPE,
2019–2026 (USD MILLION)    91
TABLE 23    3D AND 4D ULTRASOUND MARKET, BY DISPLAY TYPE,
2019–2026 (USD MILLION)    91
6.2.12    3D AND 4D ULTRASOUND MARKET, BY SYSTEM PORTABILITY,
2019–2026 (USD MILLION)    92
TABLE 24    3D AND 4D ULTRASOUND MARKET, BY SYSTEM PORTABILITY,
2019–2026 (USD MILLION)    92
6.2.13    3D AND 4D ULTRASOUND MARKET, BY APPLICATION,
2019–2026 (USD MILLION)    92
TABLE 25    3D AND 4D ULTRASOUND MARKET, BY APPLICATION,
2019–2026 (USD MILLION)    92
6.2.14    3D AND 4D ULTRASOUND MARKET, BY END USER,
2019–2026 (USD MILLION)    93
TABLE 26    3D AND 4D ULTRASOUND MARKET, BY END USER,
2019–2026 (USD MILLION)    93
6.2.15    DOPPLER ULTRASOUND    93
6.2.15.1    Growing application in pain management, cardiovascular imaging, and emergency care to drive market growth    93
TABLE 27    DOPPLER ULTRASOUND MARKET, BY REGION, 2019–2026 (USD MILLION)    94
6.2.16    DOPPLER ULTRASOUND MARKET, BY DISPLAY TYPE,
2019–2026 (USD MILLION)    94
TABLE 28    DOPPLER ULTRASOUND MARKET, BY DISPLAY TYPE,
2019–2026 (USD MILLION)    94
6.2.17    DOPPLER ULTRASOUND MARKET, BY SYSTEM PORTABILITY,
2019–2026 (USD MILLION)    95
TABLE 29    DOPPLER ULTRASOUND MARKET, BY SYSTEM PORTABILITY,
2019–2026 (USD MILLION)    95
6.2.18    DOPPLER ULTRASOUND MARKET, BY APPLICATION,
2019–2026 (USD MILLION)    95
TABLE 30    DOPPLER ULTRASOUND MARKET, BY APPLICATION,
2019–2026 (USD MILLION)    95
6.2.19    DOPPLER ULTRASOUND MARKET, BY END USER, 2019–2026 (USD MILLION)    96
TABLE 31    DOPPLER ULTRASOUND MARKET, BY END USER, 2019–2026 (USD MILLION)    96
6.3    THERAPEUTIC ULTRASOUND    96
TABLE 32    THERAPEUTIC ULTRASOUND MARKET, BY TYPE, 2019–2026 (USD MILLION)    96
TABLE 33    THERAPEUTIC ULTRASOUND MARKET, BY REGION,
2019–2026 (USD MILLION)    97
6.3.1    THERAPEUTIC ULTRASOUND MARKET, BY DISPLAY TYPE,
2019–2026 (USD MILLION)    97
TABLE 34    THERAPEUTIC ULTRASOUND MARKET, BY DISPLAY TYPE,
2019–2026 (USD MILLION)    97
6.3.2    THERAPEUTIC ULTRASOUND MARKET, BY SYSTEM PORTABILITY,
2019–2026 (USD MILLION)    98
TABLE 35    THERAPEUTIC ULTRASOUND MARKET, BY SYSTEM PORTABILITY,
2019–2026 (USD MILLION)    98
6.3.3    THERAPEUTIC ULTRASOUND MARKET, BY APPLICATION,
 2019–2026 (USD MILLION)    98
TABLE 36    THERAPEUTIC ULTRASOUND MARKET, BY APPLICATION,
2019–2026 (USD MILLION)    98
6.3.4    THERAPEUTIC ULTRASOUND MARKET, BY END USER,
2019–2026 (USD MILLION)    99
TABLE 37    THERAPEUTIC ULTRASOUND MARKET, BY END USER,
2019–2026 (USD MILLION)    99
6.3.5    EXTRACORPOREAL SHOCKWAVE LITHOTRIPSY    99
6.3.5.1    Growing emphasis on the minimally invasive treatment of kidney and gall bladder stones to drive the demand for ESWL    99
TABLE 38    ESWL ULTRASOUND MARKET, BY REGION, 2019–2026 (USD MILLION)    100
6.3.6    ESWL ULTRASOUND MARKET, BY DISPLAY TYPE, 2019–2026 (USD MILLION)    100
TABLE 39    ESWL ULTRASOUND MARKET, BY DISPLAY TYPE, 2019–2026 (USD MILLION)    100
6.3.7    ESWL ULTRASOUND MARKET, BY SYSTEM PORTABILITY,
2019–2026 (USD MILLION)    101
TABLE 40    ESWL ULTRASOUND MARKET, BY SYSTEM PORTABILITY,
2019–2026 (USD MILLION)    101
6.3.8    ESWL ULTRASOUND MARKET, BY APPLICATION, 2019–2026 (USD MILLION)    101
TABLE 41    ESWL ULTRASOUND MARKET, BY APPLICATION, 2019–2026 (USD MILLION)    101
6.3.9    ESWL ULTRASOUND MARKET, BY END USER, 2019–2026 (USD MILLION)    102
TABLE 42    ESWL ULTRASOUND MARKET, BY END USER, 2019–2026 (USD MILLION)    102
6.3.10    HIGH-INTENSITY FOCUSED ULTRASOUND    102
6.3.10.1    Promising results associated with HIFU for the treatment of various cancers to drive market growth    102
TABLE 43    HIFU ULTRASOUND MARKET, BY REGION, 2019–2026 (USD MILLION)    103
6.3.11    HIFU ULTRASOUND MARKET, BY DISPLAY TYPE, 2019–2026 (USD MILLION)    103
TABLE 44    HIFU ULTRASOUND MARKET, BY DISPLAY TYPE, 2019–2026 (USD MILLION)    103
6.3.12    HIFU ULTRASOUND MARKET, BY SYSTEM PORTABILITY,
2019–2026 (USD MILLION)    104
TABLE 45    HIFU ULTRASOUND MARKET, BY SYSTEM PORTABILITY,
2019–2026 (USD MILLION)    104
6.3.13    HIFU ULTRASOUND MARKET, BY APPLICATION, 2019–2026 (USD MILLION)    104
TABLE 46    HIFU ULTRASOUND MARKET, BY APPLICATION, 2019–2026 (USD MILLION)    104
6.3.14    HIFU ULTRASOUND MARKET, BY END USER, 2019–2026 (USD MILLION)    105
TABLE 47    HIFU ULTRASOUND MARKET, BY END USER, 2019–2026 (USD MILLION)    105

7    ULTRASOUND MARKET, BY SYSTEM PORTABILITY    106
7.1    INTRODUCTION    107
TABLE 48    ULTRASOUND MARKET, BY SYSTEM PORTABILITY,
2019–2026 (USD MILLION)    107
7.2    TROLLEY/CART-BASED DEVICES    107
7.2.1    INCREASED USE OF TROLLEY-BASED SYSTEMS FOR ACUTE CARE & EMERGENCY CARE TO DRIVE MARKET GROWTH    107
TABLE 49    ULTRASOUND MARKET FOR TROLLEY/CART-BASED DEVICES, BY REGION, 2019–2026 (USD MILLION)    108
7.3    COMPACT/TABLE-TOP DEVICES    108
7.3.1    DEVICE AFFORDABILITY AS WELL AS PROCEDURAL & TECHNICAL BENEFITS TO DRIVE THE DEMAND FOR TABLE-TOP DEVICES    108
TABLE 50    ULTRASOUND MARKET FOR COMPACT/TABLE-TOP DEVICES, BY REGION, 2019–2026 (USD MILLION)    109
7.4    POC/PORTABLE DEVICES    109
7.4.1    IMPROVED OPERATIONAL AND CLINICAL EFFICACY TO BOOST THE DEMAND FOR POC ULTRASOUND DEVICES    109
TABLE 51    ULTRASOUND MARKET FOR POC/PORTABLE DEVICES, BY REGION,
2019–2026 (USD MILLION)    110
8    ULTRASOUND MARKET, BY DISPLAY TYPE    111
8.1    INTRODUCTION    112
TABLE 52    ULTRASOUND MARKET, BY DISPLAY TYPE, 2019–2026 (USD MILLION)    112
8.2    COLOR ULTRASOUND DEVICES    112
8.2.1    GREATER MARKET AVAILABILITY OF ADVANCED COLOR ULTRASOUND DEVICES TO DRIVE THE MARKET    112
TABLE 53    COLOR ULTRASOUND DEVICES MARKET, BY REGION,
2019–2026 (USD MILLION)    113
8.3    BLACK & WHITE ULTRASOUND DEVICES    113
8.3.1    ASIA PACIFIC REGION TO REGISTER SUSTAINED DEMAND FOR B/W ULTRASOUND DEVICES    113
TABLE 54    BLACK & WHITE ULTRASOUND DEVICES MARKET, BY REGION,
2019–2026 (USD MILLION)    114
9    ULTRASOUND MARKET, BY APPLICATION    115
9.1    INTRODUCTION    116
TABLE 55    ULTRASOUND MARKET, BY APPLICATION, 2019–2026 (USD MILLION)    116
9.2    RADIOLOGY/GENERAL IMAGING APPLICATIONS    116
9.2.1    GROWING NUMBER OF IMAGE-GUIDED SURGERIES/RADIOLOGY PROCEDURES TO DRIVE THE GROWTH OF THIS APPLICATION SEGMENT    116
TABLE 56    ULTRASOUND MARKET FOR RADIOLOGY/GENERAL IMAGING APPLICATIONS, BY REGION, 2019–2026 (USD MILLION)    117
9.3    CARDIOLOGY APPLICATIONS    117
9.3.1    RISING PREVALENCE OF CARDIAC DISORDERS TO DRIVE THE GROWTH OF THIS APPLICATION SEGMENT    117
TABLE 57    ULTRASOUND MARKET FOR CARDIOLOGY APPLICATIONS, BY REGION,
2019–2026 (USD MILLION)    118
9.4    OBSTETRICS/GYNECOLOGY APPLICATIONS    118
9.4.1    ULTRASOUND IS WIDELY USED IN THE FIELD OF OBSTETRICS AND GYNECOLOGY    118
TABLE 58    ULTRASOUND MARKET FOR OBSTETRICS/GYNECOLOGY APPLICATIONS,
BY REGION, 2019–2026 (USD MILLION)    119
9.5    VASCULAR APPLICATIONS    119
9.5.1    VASCULAR APPLICATIONS SEGMENT TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD    119
TABLE 59    ULTRASOUND MARKET FOR VASCULAR APPLICATIONS, BY REGION,
2019–2026 (USD MILLION)    120
9.6    UROLOGICAL APPLICATIONS    120
9.6.1    ULTRASOUND IS WIDELY USED IN THE DIAGNOSIS AND TREATMENT OF VARIOUS UROLOGICAL DISORDERS    120
TABLE 60    ULTRASOUND MARKET FOR UROLOGICAL APPLICATIONS, BY REGION,
2019–2026 (USD MILLION)    121
9.7    ORTHOPEDIC AND MUSCULOSKELETAL APPLICATIONS    121
9.7.1    RISING PATIENT PREFERENCE FOR EFFECTIVE & EARLY DISEASE DIAGNOSIS TO DRIVE THE GROWTH OF THIS APPLICATION SEGMENT    121
TABLE 61    ULTRASOUND MARKET FOR ORTHOPEDIC AND MUSCULOSKELETAL APPLICATIONS, BY REGION, 2019–2026 (USD MILLION)    122
9.8    PAIN MANAGEMENT APPLICATIONS    122
9.8.1    ULTRASOUND DEVICES ARE INCREASINGLY BEING UTILIZED FOR TRAUMA & EMERGENCY CARE APPLICATIONS    122
TABLE 62    ULTRASOUND MARKET FOR PAIN MANAGEMENT APPLICATIONS, BY REGION, 2019–2026 (USD MILLION)    123
9.9    OTHER APPLICATIONS    123
TABLE 63    ULTRASOUND MARKET FOR OTHER APPLICATIONS, BY REGION,
2019–2026 (USD MILLION)    123
10    ULTRASOUND MARKET, BY COMPONENT    124
10.1    INTRODUCTION    125
TABLE 64    ULTRASOUND MARKET, BY COMPONENT, 2019–2026 (USD MILLION)    125
10.2    TRANSDUCERS/PROBES    125
TABLE 65    TRANSDUCERS/PROBES MARKET, BY TYPE, 2019–2026 (USD MILLION)    126
TABLE 66    TRANSDUCERS/PROBES MARKET, BY REGION, 2019–2026 (USD MILLION)    126
10.2.1    CURVILINEAR/CONVEX ARRAY PROBES    127
10.2.1.1    Growing adoption of POC ultrasound to drive the growth of this market segment    127
TABLE 67    CURVILINEAR/CONVEX ARRAY PROBES MARKET, BY REGION,
2019–2026 (USD MILLION)    127
10.2.2    LINER ARRAY PROBES    127
10.2.2.1    Increasing target patient population to drive the growth of this market segment    127
TABLE 68    LINEAR ARRAY PROBES MARKET, BY REGION, 2019–2026 (USD MILLION)    128
10.2.3    PHASED ARRAY PROBES    128
10.2.3.1    Technological advancements to drive the growth of this market segment    128
TABLE 69    PHASED ARRAY PROBES MARKET, BY REGION, 2019–2026 (USD MILLION)    128
10.2.4    OTHER PROBES    129
TABLE 70    OTHER PROBES MARKET, BY REGION, 2019–2026 (USD MILLION)    129
10.3    WORKSTATIONS    129
10.3.1    INCREASING NUMBER OF DIAGNOSTIC PROCEDURES TO DRIVE THE GROWTH OF THIS MARKET SEGMENT    129
TABLE 71    WORKSTATIONS MARKET, BY REGION, 2019–2026 (USD MILLION)    130
10.4    OTHER COMPONENTS    130
TABLE 72    OTHER COMPONENTS MARKET, BY REGION, 2019–2026 (USD MILLION)    130
11    ULTRASOUND MARKET, BY END USER    131
11.1    INTRODUCTION    132
TABLE 73    ULTRASOUND MARKET, BY END USER, 2019–2026 (USD MILLION)    132
11.2    HOSPITALS, SURGICAL CENTERS, AND DIAGNOSTIC CENTERS    132
11.2.1    SIGNIFICANT NUMBER OF ULTRASOUND-BASED MEDICAL PROCEDURES ARE PERFORMED IN THESE FACILITIES    132
TABLE 74    ULTRASOUND MARKET FOR HOSPITALS, SURGICAL CENTERS, AND DIAGNOSTIC CENTERS, BY REGION, 2019–2026 (USD MILLION)    133
11.3    MATERNITY CENTERS    134
11.3.1    INCREASED ADOPTION OF ADVANCED 3D, 4D, AND DOPPLER ULTRASOUND FOR OB/GYN APPLICATIONS TO DRIVE MARKET GROWTH    134
TABLE 75    ULTRASOUND MARKET FOR MATERNITY CENTERS, BY REGION,
2019–2026 (USD MILLION)    134
11.4    AMBULATORY CARE CENTERS    135
11.4.1    GROWING NUMBER OF MINIMALLY INVASIVE PROCEDURES PERFORMED AT AMBULATORY CARE CENTERS TO DRIVE MARKET GROWTH    135
TABLE 76    ULTRASOUND MARKET FOR AMBULATORY CARE CENTERS, BY REGION, 2019–2026 (USD MILLION)    135
11.5    RESEARCH AND ACADEMIA    136
11.5.1    GROWING RESEARCH GRANTS AND FUNDING TO DRIVE THE GROWTH OF THIS END-USER SEGMENT    136
TABLE 77    ULTRASOUND MARKET FOR RESEARCH AND ACADEMIA, BY REGION,
2019–2026 (USD MILLION)    136
11.6    OTHER END USERS    137
FIGURE 29    NUMBER OF SPORTS INJURIES (2020)    137
TABLE 78    ULTRASOUND MARKET FOR OTHER END USERS, BY REGION,
2019–2026 (USD MILLION)    138

12    ULTRASOUND MARKET, BY REGION    139
12.1    INTRODUCTION    140
TABLE 79    ULTRASOUND MARKET, BY REGION, 2019–2026 (USD MILLION)    140
12.2    EUROPE    141
FIGURE 30    EUROPE: ULTRASOUND MARKET SNAPSHOT    141
TABLE 80    EUROPE: ULTRASOUND MARKET, BY COUNTRY, 2019–2026 (USD MILLION)    142
TABLE 81    EUROPE: ULTRASOUND MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION)    142
TABLE 82    EUROPE: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE,
2019–2026 (USD MILLION)    142
TABLE 83    EUROPE: THERAPEUTIC ULTRASOUND MARKET, BY TYPE,
2019–2026 (USD MILLION)    143
TABLE 84    EUROPE: ULTRASOUND MARKET, BY DISPLAY TYPE,
2019–2026 (USD MILLION)    143
TABLE 85    EUROPE: ULTRASOUND MARKET, BY SYSTEM PORTABILITY,
2019–2026 (USD MILLION)    143
TABLE 86    EUROPE: ULTRASOUND MARKET, BY APPLICATION,
2019–2026 (USD MILLION)    144
TABLE 87    EUROPE: ULTRASOUND MARKET, BY COMPONENT,
2019–2026 (USD MILLION)    144
TABLE 88    EUROPE: ULTRASOUND MARKET FOR TRANSDUCERS/PROBES, BY TYPE, 2019–2026 (USD MILLION)    145
TABLE 89    EUROPE: ULTRASOUND MARKET, BY END USER, 2019–2026 (USD MILLION)    145
12.2.1    GERMANY    146
12.2.1.1    Wide acceptance of advanced technologies and favorable reimbursement scenario to drive market growth    146
TABLE 90    GERMANY: ULTRASOUND MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION)    146
TABLE 91    GERMANY: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE,
2019–2026 (USD MILLION)    147
TABLE 92    GERMANY: THERAPEUTIC ULTRASOUND MARKET, BY TYPE,
2019–2026 (USD MILLION)    147
12.2.2    UK    147
12.2.2.1    Rising geriatric population to drive market growth in the UK    147
TABLE 93    UK: ULTRASOUND MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)    148
TABLE 94    UK: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE,
2019–2026 (USD MILLION)    148
TABLE 95    UK: THERAPEUTIC ULTRASOUND MARKET, BY TYPE,
2019–2026 (USD MILLION)    149
12.2.3    FRANCE    149
12.2.3.1    Modernization of healthcare infrastructure fueling the demand for ultrasound systems    149
TABLE 96    FRANCE: ULTRASOUND MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION)    150
TABLE 97    FRANCE: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE,
2019–2026 (USD MILLION)    150
TABLE 98    FRANCE: THERAPEUTIC ULTRASOUND MARKET, BY TYPE,
2019–2026 (USD MILLION)    150
12.2.4    ITALY    151
12.2.4.1    Improved reimbursement scenario and increasing R&D to support overall market growth    151
TABLE 99    ITALY: ULTRASOUND MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)    151
TABLE 100    ITALY: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE,
2019–2026 (USD MILLION)    151
TABLE 101    ITALY: THERAPEUTIC ULTRASOUND MARKET, BY TYPE,
2019–2026 (USD MILLION)    152
12.2.5    SPAIN    152
12.2.5.1    Low entry barriers to create opportunities for global players to expand their presence in the country    152
TABLE 102    SPAIN: ULTRASOUND MARKET, BY TECHNOLOGY,
 2019–2026 (USD MILLION)    153
TABLE 103    SPAIN: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE,
2019–2026 (USD MILLION)    153
TABLE 104    SPAIN: THERAPEUTIC ULTRASOUND MARKET, BY TYPE,
2019–2026 (USD MILLION)    153
12.2.6    REST OF EUROPE    154
TABLE 105    REST OF EUROPE: ULTRASOUND MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION)    154
TABLE 106    REST OF EUROPE: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE,
2019–2026 (USD MILLION)    155
TABLE 107    REST OF EUROPE: THERAPEUTIC ULTRASOUND MARKET, BY TYPE,
2019–2026 (USD MILLION)    155
12.3    NORTH AMERICA    156
TABLE 108    NORTH AMERICA: ULTRASOUND MARKET, BY COUNTRY,
2019–2026 (USD MILLION)    156
TABLE 109    NORTH AMERICA: ULTRASOUND MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION)    156
TABLE 110    NORTH AMERICA: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE,
2019–2026 (USD MILLION)    157
TABLE 111    NORTH AMERICA: THERAPEUTIC ULTRASOUND MARKET, BY TYPE,
2019–2026 (USD MILLION)    157
TABLE 112    NORTH AMERICA: ULTRASOUND MARKET, BY DISPLAY TYPE,
2019–2026 (USD MILLION)    157
TABLE 113    NORTH AMERICA: ULTRASOUND MARKET, BY SYSTEM PORTABILITY,
2019–2026 (USD MILLION)    158
TABLE 114    NORTH AMERICA: ULTRASOUND MARKET, BY APPLICATION,
2019–2026 (USD MILLION)    158
TABLE 115    NORTH AMERICA: ULTRASOUND MARKET, BY COMPONENT,
2019–2026 (USD MILLION)    159
TABLE 116    NORTH AMERICA: ULTRASOUND MARKET FOR TRANSDUCERS/PROBES,
BY TYPE, 2019–2026 (USD MILLION)    159
TABLE 117    NORTH AMERICA: ULTRASOUND MARKET, BY END USER,
2019–2026 (USD MILLION)    160

12.3.1    US    160
12.3.1.1    The US dominated the North American ultrasound market    160
TABLE 118    POCUS ULTRASOUND CPT CODES (2021)    161
TABLE 119    CPT CODES FOR ULTRASOUND-GUIDED PROCEDURES (2021)    164
TABLE 120    US: ULTRASOUND MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)    165
TABLE 121    US: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE,
2019–2026 (USD MILLION)    165
TABLE 122    US: THERAPEUTIC ULTRASOUND MARKET, BY TYPE,
2019–2026 (USD MILLION)    166
12.3.2    CANADA    166
12.3.2.1    Growing awareness about early disease diagnosis to drive market growth in Canada    166
TABLE 123    CANADA: ULTRASOUND MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION)    167
TABLE 124    CANADA: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE,
2019–2026 (USD MILLION)    167
TABLE 125    CANADA: THERAPEUTIC ULTRASOUND MARKET, BY TYPE,
2019–2026 (USD MILLION)    168
12.4    ASIA PACIFIC    168
FIGURE 31    ASIA PACIFIC: ULTRASOUND MARKET SNAPSHOT    169
TABLE 126    ASIA PACIFIC: ULTRASOUND MARKET, BY COUNTRY,
2019–2026 (USD MILLION)    170
TABLE 127    ASIA PACIFIC: ULTRASOUND MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION)    170
TABLE 128    ASIA PACIFIC: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE,
2019–2026 (USD MILLION)    170
TABLE 129    ASIA PACIFIC: THERAPEUTIC ULTRASOUND MARKET, BY TYPE,
2019–2026 (USD MILLION)    171
TABLE 130    ASIA PACIFIC: ULTRASOUND MARKET, BY DISPLAY TYPE,
2019–2026 (USD MILLION)    171
TABLE 131    ASIA PACIFIC: ULTRASOUND MARKET, BY SYSTEM PORTABILITY,
2019–2026 (USD MILLION)    171
TABLE 132    ASIA PACIFIC: ULTRASOUND MARKET, BY APPLICATION,
2019–2026 (USD MILLION)    172
TABLE 133    ASIA PACIFIC: ULTRASOUND MARKET, BY COMPONENT,
2019–2026 (USD MILLION)    172
TABLE 134    ASIA PACIFIC: ULTRASOUND MARKET FOR TRANSDUCERS/PROBES,
BY TYPE, 2019–2026 (USD MILLION)    173
TABLE 135    ASIA PACIFIC: ULTRASOUND MARKET, BY END USER,
2019–2026 (USD MILLION)    173
12.4.1    CHINA    174
12.4.1.1    Increasing patient pool and localized manufacturing to drive the market growth    174
TABLE 136    CHINA: ULTRASOUND MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION)    175
TABLE 137    CHINA: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE,
2019–2026 (USD MILLION)    175
TABLE 138    CHINA: THERAPEUTIC ULTRASOUND MARKET, BY TYPE,
2019–2026 (USD MILLION)    175
12.4.2    JAPAN    176
12.4.2.1    Rising geriatric population to boost market growth in Japan    176
TABLE 139    JAPAN: ULTRASOUND MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION)    176
TABLE 140    JAPAN: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE,
2019–2026 (USD MILLION)    177
TABLE 141    JAPAN: THERAPEUTIC ULTRASOUND MARKET, BY TYPE,
2019–2026 (USD MILLION)    177
12.4.3    INDIA    177
12.4.3.1    Significant burden of target diseases and availability of affordable devices to drive market growth    177
TABLE 142    INDIA: ULTRASOUND MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)    178
TABLE 143    INDIA: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE,
2019–2026 (USD MILLION)    178
TABLE 144    INDIA: THERAPEUTIC ULTRASOUND MARKET, BY TYPE,
2019–2026 (USD MILLION)    179
12.4.4    SOUTH KOREA    179
12.4.4.1    Supportive government initiatives in the country to positively impact market growth    179
TABLE 145    SOUTH KOREA: ULTRASOUND MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION)    180
TABLE 146    SOUTH KOREA: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE,
2019–2026 (USD MILLION)    180
TABLE 147    SOUTH KOREA: THERAPEUTIC ULTRASOUND MARKET, BY TYPE,
2019–2026 (USD MILLION)    181
12.4.5    AUSTRALIA    181
12.4.5.1    Growing research investments and awareness campaigns to drive market growth in Australia    181
TABLE 148    AUSTRALIA: ULTRASOUND REIMBURSEMENT SCENARIO    181
TABLE 149    AUSTRALIA: ULTRASOUND MARKET, BY TECHNOLOGY,
 2019–2026 (USD MILLION)    184
TABLE 150    AUSTRALIA: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE,
2019–2026 (USD MILLION)    185
TABLE 151    AUSTRALIA: THERAPEUTIC ULTRASOUND MARKET, BY TYPE,
2019–2026 (USD MILLION)    185
12.4.6    REST OF ASIA PACIFIC    185
TABLE 152    ROAPAC: ULTRASOUND MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION)    186
TABLE 153    ROAPAC: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE,
2019–2026 (USD MILLION)    186
TABLE 154    ROAPAC: THERAPEUTIC ULTRASOUND MARKET, BY TYPE,
2019–2026 (USD MILLION)    186

12.5    LATIN AMERICA    187
TABLE 155    LATIN AMERICA: ULTRASOUND MARKET, BY COUNTRY,
2019–2026 (USD MILLION)    187
TABLE 156    LATIN AMERICA: ULTRASOUND MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION)    187
TABLE 157    LATIN AMERICA: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE,
2019–2026 (USD MILLION)    188
TABLE 158    LATIN AMERICA: THERAPEUTIC ULTRASOUND MARKET, BY TYPE,
2019–2026 (USD MILLION)    188
TABLE 159    LATIN AMERICA: ULTRASOUND MARKET, BY DISPLAY TYPE,
2019–2026 (USD MILLION)    188
TABLE 160    LATIN AMERICA: ULTRASOUND MARKET, BY SYSTEM PORTABILITY,
2019–2026 (USD MILLION)    189
TABLE 161    LATIN AMERICA: ULTRASOUND MARKET, BY APPLICATION,
2019–2026 (USD MILLION)    189
TABLE 162    LATIN AMERICA: ULTRASOUND MARKET, BY COMPONENT,
2019–2026 (USD MILLION)    190
TABLE 163    LATIN AMERICA: ULTRASOUND MARKET FOR TRANSDUCERS/PROBES,
BY TYPE, 2019–2026 (USD MILLION)    190
TABLE 164    LATIN AMERICA: ULTRASOUND MARKET, BY END USER,
2019–2026 (USD MILLION)    191
12.5.1    BRAZIL    191
12.5.1.1    Universal healthcare system to play a pivotal role in driving the use of ultrasound for disease diagnosis    191
TABLE 165    BRAZIL: ULTRASOUND MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION)    192
TABLE 166    BRAZIL: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE,
2019–2026 (USD MILLION)    192
TABLE 167    BRAZIL: THERAPEUTIC ULTRASOUND MARKET, BY TYPE,
2019–2026 (USD MILLION)    192
12.5.2    MEXICO    193
12.5.2.1    Modernization of healthcare infrastructure to support market growth in Mexico    193
TABLE 168    MEXICO: ULTRASOUND MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION)    193
TABLE 169    MEXICO: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE,
2019–2026 (USD MILLION)    193
TABLE 170    MEXICO: THERAPEUTIC ULTRASOUND MARKET, BY TYPE,
2019–2026 (USD MILLION)    194
12.5.3    REST OF LATIN AMERICA    194
TABLE 171    ROLA: ULTRASOUND MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)    195
TABLE 172    ROLA: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE,
2019–2026 (USD MILLION)    195
TABLE 173    ROLA: THERAPEUTIC ULTRASOUND MARKET, BY TYPE,
2019–2026 (USD MILLION)    195

12.6    MIDDLE EAST & AFRICA    196
12.6.1    IMPROVING HEALTHCARE INFRASTRUCTURE AND INCREASING PUBLIC-PRIVATE INVESTMENTS TO DRIVE MARKET GROWTH IN THE MEA REGION    196
TABLE 174    MEA: ULTRASOUND MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)    196
TABLE 175    MEA: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE,
2019–2026 (USD MILLION)    197
TABLE 176    MEA: THERAPEUTIC ULTRASOUND MARKET, BY TYPE,
2019–2026 (USD MILLION)    197
TABLE 177    MEA: ULTRASOUND MARKET, BY DISPLAY TYPE, 2019–2026 (USD MILLION)    197
TABLE 178    MEA: ULTRASOUND MARKET, BY SYSTEM PORTABILITY,
2019–2026 (USD MILLION)    198
TABLE 179    MEA: ULTRASOUND MARKET, BY APPLICATION, 2019–2026 (USD MILLION)    198
TABLE 180    MEA: ULTRASOUND MARKET, BY COMPONENT, 2019–2026 (USD MILLION)    199
TABLE 181    MEA: ULTRASOUND MARKET FOR TRANSDUCERS/PROBES, BY TYPE,
2019–2026 (USD MILLION)    199
TABLE 182    MEA: ULTRASOUND MARKET, BY END USER, 2019–2026 (USD MILLION)    200
13    COMPETITIVE LANDSCAPE    201
13.1    OVERVIEW    201
13.2    KEY PLAYER STRATEGIES    201
FIGURE 32    KEY DEVELOPMENTS IN THE ULTRASOUND MARKET (2018 TO 2021)    202
13.3    REVENUE SHARE ANALYSIS    203
FIGURE 33    REVENUE SHARE ANALYSIS OF THE TOP PLAYERS IN THE ULTRASOUND MARKET    203
13.4    MARKET SHARE ANALYSIS: ULTRASOUND MARKET, BY KEY PLAYER (2020)    204
FIGURE 34    GE HEALTHCARE HELD THE LEADING POSITION IN THE ULTRASOUND MARKET IN 2020    204
TABLE 183    ULTRASOUND MARKET: DEGREE OF COMPETITION    205
13.5    COMPANY EVALUATION QUADRANT FOR 25 KEY PLAYERS (2020)    206
13.5.1    TERMINOLOGY/NOMENCLATURE    206
13.5.1.1    Stars    206
13.5.1.2    Emerging leaders    206
13.5.1.3    Pervasive players    206
13.5.1.4    Participants    206
FIGURE 35    ULTRASOUND MARKET: COMPETITIVE LEADERSHIP MAPPING, 2020    207
13.6    COMPANY EVALUATION QUADRANT FOR START-UP/SMES (2020)    208
13.6.1    PROGRESSIVE COMPANIES    208
13.6.2    RESPONSIVE COMPANIES    208
13.6.3    DYNAMIC COMPANIES    208
13.6.4    STARTING BLOCKS    208
FIGURE 36    ULTRASOUND MARKET: COMPETITIVE LEADERSHIP MAPPING
(SME/START-UPS)    209
13.7    COMPETITIVE BENCHMARKING    210
TABLE 184    APPLICATION FOOTPRINT ANALYSIS OF THE TOP PLAYERS IN
THE ULTRASOUND MARKET    210
13.8    COMPETITIVE SCENARIO (2018–2021)    210
13.8.1    NEW PRODUCT LAUNCHES AND APPROVALS    210
TABLE 185    ULTRASOUND MARKET: NEW PRODUCT LAUNCHES AND APPROVALS,
2018–2021    210
13.8.2    DEALS    211
TABLE 186    ULTRASOUND MARKET: DEALS, 2018–2021    211
13.8.3    EXPANSIONS    212
TABLE 187    ULTRASOUND MARKET: EXPANSIONS, 2018–2021    212
14    COMPANY PROFILES    213
14.1    INTRODUCTION    213
14.2    KEY PLAYERS    214
(Business overview, Products offered, Recent developments, MNM view)*
14.2.1    GE HEALTHCARE    214
TABLE 188    GE HEALTHCARE: BUSINESS OVERVIEW    214
FIGURE 37    GE HEALTHCARE: COMPANY SNAPSHOT (2020)    215
14.2.2    KONINKLIJKE PHILIPS N.V.    219
TABLE 189    KONINKLIJKE PHILIPS N.V.: BUSINESS OVERVIEW    219
FIGURE 38    KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2020)    220
14.2.3    CANON MEDICAL SYSTEMS CORPORATION    224
TABLE 190    CANON MEDICAL SYSTEMS CORPORATION: BUSINESS OVERVIEW    224
FIGURE 39    CANON MEDICAL SYSTEMS CORPORATION: COMPANY SNAPSHOT (2020)    225
14.2.4    SIEMENS AG    228
TABLE 191    SIEMENS AG: BUSINESS OVERVIEW    228
FIGURE 40    SIEMENS HEALTHINEERS AG: COMPANY SNAPSHOT    229
14.2.5    HITACHI, LTD.    232
TABLE 192    HITACHI, LTD.: BUSINESS OVERVIEW    232
FIGURE 41    HITACHI, LTD.: COMPANY SNAPSHOT    233
14.2.6    HOLOGIC, INC.    236
TABLE 193    HOLOGIC, INC.: BUSINESS OVERVIEW    236
FIGURE 42    HOLOGIC, INC.: COMPANY SNAPSHOT    237
14.2.7    FUJIFILM HOLDINGS CORPORATION    239
TABLE 194    FUJIFILM HOLDINGS CORPORATION: BUSINESS OVERVIEW    239
FIGURE 43    FUJIFILM HOLDINGS CORPORATION: COMPANY SNAPSHOT    240
14.2.8    SAMSUNG ELECTRONICS CO., LTD.    243
TABLE 195    SAMSUNG ELECTRONICS CO., LTD.: BUSINESS OVERVIEW    243
FIGURE 44    SAMSUNG ELECTRONICS CO., LTD.: COMPANY SNAPSHOT    244
14.2.9    MINDRAY MEDICAL INTERNATIONAL LIMITED    247
TABLE 196    MINDRAY MEDICAL INTERNATIONAL LIMITED: BUSINESS OVERVIEW    247
FIGURE 45    MINDRAY MEDICAL INTERNATIONAL LIMITED: COMPANY SNAPSHOT    247
14.2.10    ANALOGIC CORPORATION    250
TABLE 197    ANALOGIC CORPORATION: BUSINESS OVERVIEW    250
14.2.11    ESAOTE SPA    252
TABLE 198    ESAOTE S.P.A: BUSINESS OVERVIEW    252
14.2.12    CARESTREAM HEALTH    255
TABLE 199    CARESTREAM HEALTH: BUSINESS OVERVIEW    255
FIGURE 46    ONEX CORPORATION: COMPANY SNAPSHOT    255
14.2.13    CURA HEALTHCARE    257
TABLE 200    CURA HEALTHCARE: BUSINESS OVERVIEW    257
14.2.14    CHISON MEDICAL TECHNOLOGIES CO., LTD.    258
TABLE 201    CHISON MEDICAL TECHNOLOGIES CO., LTD.: BUSINESS OVERVIEW    258
*Business overview, Products offered, Recent developments, MNM view might not be captured in case of unlisted companies.
14.3    OTHER COMPANIES    260
14.3.1    MOBISANTE, INC.    260
14.3.2    NEUSOFT CORPORATION    261
14.3.3    CLARIUS MOBILE HEALTH    262
14.3.4    MEDGYN PRODUCTS, INC.    262
14.3.5    UNITED IMAGING HEALTHCARE CO., LTD.    263
14.3.6    PROMED TECHNOLOGY CO., LTD.    264
14.3.7    CEPHASONICS    265
14.3.8    UAB TELEMED    265
14.3.9    SHENZHEN RICSO TECHNOLOGY CO., LTD.    266
14.3.10    WUHAN YOUKEY BIO-MEDICAL ELECTRONICS CO., LTD.    267
15    APPENDIX    268
15.1    DISCUSSION GUIDE    268
15.2    KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL    273
15.3    AVAILABLE CUSTOMIZATIONS    275
15.4    RELATED REPORTS    276
15.5    AUTHOR DETAILS    277"